1 / 7

Ocular Hypertension Global Clinical Trials, 2016-Latest Report

Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type

Download Presentation

Ocular Hypertension Global Clinical Trials, 2016-Latest Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Latest Report on Ocular Hypertension Global Clinical Trials, 2016

  2. Ocular Hypertension Global Clinical Trials Review, H1, 2016 Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials)  +1 408 520 9750  www.marketreportsworld.com sales@marketreportsworld.com

  3. Topics Revealed in this Report Global, Clinical Trials In Progress by Top Countries Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16  +1 408 520 9750  www.marketreportsworld.com sales@marketreportsworld.com

  4. Major/Key Manufacturers Analysis The research provides a brief overview on major companies Novartis AG Allergan Plc Pfizer Inc. Santen Pharmaceutical Co., Ltd. Aerie Pharmaceuticals, Inc. Valeant Pharmaceuticals International, Inc. Merck & Co., Inc. Kowa Company, Ltd. MatiTherapeutics Inc. QLT Inc.  +1 408 520 9750  www.marketreportsworld.com sales@marketreportsworld.com

  5. Why one should buy this report Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial assessment of the indication on a global, regional and country level  +1 408 520 9750  www.marketreportsworld.com sales@marketreportsworld.com

  6. Report Details No. Of Pages : 370 No of Tables : 21 No. Figures : 21 Price : $2500(Single User Licence)  +1 408 520 9750  www.marketreportsworld.com sales@marketreportsworld.com

  7. Contact: Mr. AmeyaPingaley  +1 408 520 9750  www.marketreportsworld.com sales@marketreportsworld.com

More Related